Clinical Trials Arena’s Post

The cell-based assays market is projected to reach USD 24.3 billion by 2029 from an estimated USD 17.3 billion in 2024, at a CAGR of 7.1% during the forecast period of 2024 to 2029 Download PDF Brochure-https://lnkd.in/dNTwNU6a The key players in the cell-based assays market include BD (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Lonza (Switzerland), Charles River Laboratories (US), Bio-Rad Laboratories, Inc. (US), Revvity (US), Sartorius AG (Germany), Corning Incorporated (US), Promega Corporation (US), Cell Signaling Technology, Inc. (US), Eurofins Scientific (Luxembourg) , Enzo Biochem, Inc. (US), Carna Biosciences, Inc. (Japan), Intertek Group plc (UK), BICO (Sweden), Cell Biolabs, Inc. (US), Reaction Biology (US), AAT Bioquest, Inc. (US), Pestka Biomedical Laboratories, Inc. (US), Neuromics (US), BPS Bioscience, Inc. (US), BellBrook Labs (US), Profacgen (US), BMG LABTECH (Germany), Hanugen Therapeutics (India), Altogen Labs (US), and BioAgilytix (US). #CellBasedAssays #DrugDiscovery #Biotechnology #Pharmaceuticals #CellCulture #HighThroughputScreening #Biomarkers #DrugDevelopment #InVitroAssays #CellularAnalysis #AssayDevelopment #DrugScreening #CellularBiology #DrugTargeting #CellularAssays #PrecisionMedicine #TherapeuticDevelopment #CellularTesting #DrugEfficacy #CellularModels #PrecisionTherapeutics #DrugDiscoveryResearch #CellularScreening #TherapeuticTargets #DrugDiscoveryTechnology #CellularPhenotyping

Sepsis Diagnostics Market Worth $890 Million Download a PDF Brochure: https://lnkd.in/dMXnZeK7 Sepsis Diagnostics Market By Technology (Microbiology, PCR, Immunoassay, microfluidics, Biomarker), Product (Media, Reagent, Instrument), Method (Automated), Test (Lab, POC), Pathogen (Bacterial, Fungal), End User & Region - Global Forecast to 2029 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: bioMérieux (France), Becton Dickinson Company (US), Danaher Corporation (US), Abbott Laboratories (US), and Roche Diagnostics (Switzerland). Other players include T2 Biosystems (US), Thermo Fisher Scientific (US), Bruker (US), EKF Diagnostics (UK), Immunexpress (Australia) Other Companies that are Operating in this Market Globally: Cytovale Inflammatix, Inc. Selux Diagnostics, Inc Hansa Biopharma  QuantuMDx AusDiagnostics DNA Electronics (DNAe) #SepsisDiagnostics #SepsisAwareness #SepsisTesting #RapidSepsisDetection #BiomarkerTesting #BloodCultureTesting #MolecularDiagnostics #PointOfCareTesting #SepsisManagement #AntimicrobialStewardship

Exploring the frontier of Vascular Research: Ncyte® Endothelial Cells. Ncyte® Endothelial Cells are the ideal tool to provide relevant predictions on your drug’s effect on endothelial cell function in combination with our endothelial barrier permeability assay or 3D sprouting assay. They can be utilized over the entire drug discovery process, from the large screening campaigns for hit identification to critical decision-making in hit-2-lead or lead optimization. Discover more and engage with our experts today: https://lnkd.in/e_bUw3XR #EndothelialCells #iPSC #Ncardia

Recent years saw molecular diagnostics emerge as the fastest growing segment within the global in vitro diagnostics (IVD) market, but where does the multi-billion- dollar molecular diagnostic market stand post pandemic? Kalorama's "The World Market for Molecular Diagnostics, 12th Edition" has the insights you need. Get a glimpse of what’s included in this insights-packed report by downloading the table of contents here: https://hubs.la/Q02f0fbn0 Companies profiled in this report include: Bio-Rad Laboratories, CareDx, Inc., Exact Sciences, GenMark Diagnostics, Grifols, Hologic, Inc., Illumina, Meridian Bioscience Inc., NanoString Technologies, Inc., Revvity and more!

Drug development is challenging – a lot of drugs in development don’t make it to market. Limited reliability of biomarker data can be one of many struggles that drug developers face. In this clip, Ernestas Sirka, Chief Scientific Officer at Inoviv, describes how they address common challenges to drug development success. One innovative solution is combining Immunoprecipitation with Mass Spectrometry (IP-MS). Discover how the groundbreaking NeuroKey-3™ assay is accelerating neurodegenerative drug discovery and development in the full webinar, available on-demand: https://hubs.li/Q02zkVc_0 #Proteomics #MassSpec #DrugDiscovery #DrugDevelopment #AlzheimersDisease #BiotechWebinar

Researchers, how would you propose to progress drug delivery systems for the posterior inner eye segment? Your solutions should ensure sustained release over at least three months for diverse therapeutics ranging from low molecular weight compounds to complex molecules. Learn more on our open science platform #opnMe: https://lnkd.in/gEDjfkdd

Explore our human M1/M2 macrophage polarization in vitro assay. A well-defined in vitro model to test the effect of drug-candidates on the M1/M2 balance!

Introducing our latest Advances in Bioanalysis Feature! Explore tailored solutions for cost-effective and timely bioanalysis, learn more about drug development optimization and bioanalysis trends, find out how context of use (COU) influences cell counting in cell therapy manufacturing, and discover how immunoassays drive bioanalysis advancements. #bioanalysis #drugdevelopment

In Vitro Diagnostics Market worth $119.4 billion by 2029 Download PDF Brochure:-https://lnkd.in/dqn9PmeT The global in vitro diagnostics market in terms of revenue was estimated to be worth $85.2 billion in 2024 and is poised to reach $119.4 billion by 2029, growing at a CAGR of 6.9% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Roche Diagnostics UK & Ireland Danaher Corporation Abbott Siemens Healthineers Sysmex Corporation Thermo Fisher Scientific, Becton, Dickinson and Company bioMérieux Bio-Rad Laboratories, Agilent Technologies, QIAGEN QuidelOrtho Diasorin Illumina, Hologic, Inc. Revvity Werfen Devyser Chembio Diagnostics, Inc. Surmodics, Inc. Menarini Silicon Biosystems SpeeDx Pty Ltd GENSPEED Biotech Accelerate Diagnostics, Merck Caris Life Sciences, Cellabs Epitope Diagnostics, Inc. Boster Biological Technology Enzo Biochem Inc Genetic Signatures Savyon Diagnostics Trivitron Healthcare mdxhealth Creative Diagnostics InBios International, Inc. Maccura Vela Diagnostics ARKRAY,Inc., #invitrodiagnostics #ivd #medicaldiagnostics #labtesting #healthcareinnovation

Great tools to study immuneresponse!